Cancer Research UK logo.
SearchDonate
  • Search

Treatment

Targeted and immunotherapy drugs for Hodgkin lymphoma

Targeted cancer drugs work by targeting the differences in cancer cells that help them grow and survive. Immunotherapy uses the immune system to recognise and attack cancer cells.

When you might have targeted cancer drugs and immunotherapy for Hodgkin lymphoma

You might have a targeted cancer drug for one of the following reasons:

  • you have stage 3 or 4 lymphoma, which is positive for a specific protein

  • your treatment isn't working

  • your lymphoma has come back (relapsed Hodgkin lymphoma)

  • you have nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). This is a rare type of Hodgkin lymphoma

Learn about the types of Hodgkin lymphoma

Types of targeted drugs for Hodgkin lymphoma

Some drugs work in more than one way. They are targeted and work with the immune system.

Monoclonal antibodies (MABs) are the most common type of targeted drug used for Hodgkin lymphoma.

Brentuximab and rituximab are a type of monoclonal antibody. They target specific proteins on lymphoma cells and help the immune system to find these cells and kill them. Because of the way they work they are sometimes called targeted immunotherapy drugs.

Read more about monoclonal antibodies

Brentuximab

Brentuximab targets a protein called CD30, which is found on Hodgkin lymphoma cells. Brentuximab sticks to the CD30 protein and delivers a drug to the cell. The drug then kills the cell.

You might have brentuximab with chemotherapy if you have stage 3 or 4 Hodgkin lymphoma. 

You could also have bentuximab if your treatment isn't working, or if it has come back. But you first need to have had one of the following:

  • a ​​ that hasn’t worked

  • two other treatments if you couldn’t have a stem cell transplant

Read more about brentuximab

Rituximab

Rituximab targets a protein called CD20, which is found on ​​ called B cells. This then flags the cells to the immune system, which picks out the cells and kills them.

You might have this as your first treatment if you have advanced stage NLPHL or relapsed NLPHL.

You usually have rituximab with chemotherapy. You might have it with a combination of chemotherapy drugs and a steroid, such as:

  • R-CHOP - rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone

  • R-ABVD - rituximab, doxorubicin, bleomycin, vinblastine and dacarbazine

  • R-CVP - rituximab, cyclophosphamide, vincristine and prednisolone

  • R-CVinbP - rituximab, cyclophosphamide, vinblastine and prednisolone

Read more about rituximab

Types of immunotherapy drugs for Hodgkin lymphoma

Pembrolizumab and nivolumab are types of immunotherapy. They stimulate the body’s immune system to fight cancer cells.

Pembrolizumab

Pembrolizumab targets and blocks proteins called PD-1 on the surface of certain immune cells called T cells. Blocking PD-1 triggers the T cells to find and kill cancer cells.

You might have pembrolizumab if you:

  • have had at least 2 previous treatments

  • have already had brentuximab

  • can't have a stem cell transplant using your own cells

Read about pembrolizumab

Nivolumab

Nivolumab also blocks the PD-1 protein that stops the immune system from working properly and attacking cancer cells.

You might have nivolumab if either:

  • your previous treatment hasn’t worked very well

  • your lymphoma has come back

Before you have nivolumab you must have had both:

  • brentuximab

  • a stem cell transplant if you were able to have one

Read more about nivolumab

How you have targeted and immunotherapy drug treatment

Into the bloodstream

You usually have targeted and immunotherapy drugs through a drip into your arm. A nurse puts a small tube (a cannula) into one of your veins and connects the drip to it.

You may need a central line. This is a long plastic tube that gives the drugs into a large vein, either in your chest or through a vein in your arm. It stays in while you’re having treatment, which may be for a few months.

Find out about central lines

As an injection under the skin

You might have rituximab as an injection under the skin. This is called a subcutaneous injection. You can only have rituximab as an injection if you’ve had at least one dose of rituximab into your bloodstream. And you didn’t have any serious side effects while you had it.

You might have a dull ache for a short time after this type of injection but it doesn’t usually hurt much. The skin in the area may go red and itchy for a while.

Side effects

Everyone is different and the side effects vary from person to person. The side effects you may have depend on:

  • which cancer drug you have

  • whether you have it alone or with other cancer drugs

  • the amount of cancer drug you have (the dose)

  • your general health

A side effect may get better or worse during your treatment. Or more side effects may develop as the treatment goes on.

A common side effect of some monoclonal antibodies is an allergic reaction to the drug. This reaction is most likely to happen during your first treatment. Your nurse might give you medicines before treatment to prevent an allergic reaction.

Possible side effects for targeted and immunotherapy drugs include:

  • skin changes such as red and sore skin or an itchy rash

  • loose watery poo (diarrhoea)

  • tiredness

  • flu-like symptoms such as chills, fever or dizziness

  • feeling or being sick

Targeted and immunotherapy drugs can cause different side effects. Some of these can be serious. Your doctor or nurse will talk to you about this. Always tell them about any side effects you have and follow the advice they give you. 

For more information about the side effects of your treatment, go to the individual drug pages. 

A to Z list of cancer drugs

Research into immunotherapy and targeted drugs for Hodgkin lymphoma

You might have treatment as part of a clinical trial for Hodgkin lymphoma.

Researchers are looking at:

  • having immunotherapy or targeted cancer drugs as the first treatment for Hodgkin lymphoma

  • new targeted and immunotherapy drugs

  • different combinations of these cancer drugs with other treatments

Find a clinical trial looking at the treatment of Hodgkin lymphoma

When you go home

Treatment with immunotherapy or targeted cancer drugs can be difficult to cope with for some people. Your nurse will give you a number to call (advice line) if you have any problems at home.

Last reviewed: 02 Jul 2024

Next review due: 02 Jul 2027

Treatment for Hodgkin lymphoma

The main treatments for Hodgkin lymphoma include chemotherapy and radiotherapy. The treatment you have depends on a number of things such as the type and stage of Hodgkin lymphoma and your general health.

Living with Hodgkin lymphoma

Get practical and emotional support to help you cope with a diagnosis of Hodgkin lymphoma, and life during and after treatment.

Treatment options for Hodgkin lymphoma

Hodgkin lymphoma treatment is usually very successful and most people are cured. The treatment you have depends on the type and stage of your Hodgkin lymphoma, as well as your general health. You might have more than one treatment.

Chemotherapy for Hodgkin lymphoma

Read about chemotherapy and the drugs used to treat Hodgkin lymphoma.

Research and clinical trials for Hodgkin lymphoma

All cancer treatments must be fully researched before they can be used for everyone. This is so we know that they work, are better than the treatments already available, and are safe. Current research is looking at ways to improve the diagnosis and treatment of Hodgkin lymphoma.

Hodgkin lymphoma main page

Hodgkin lymphoma is a cancer of a type of white blood cell called lymphocytes. Find out more about the tests, treatments and support available if you have Hodgkin lymphoma.

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and Support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.